Lv0
0 积分 2022-07-13 加入
SHR-2004, a Humanized Monoclonal Antibody Targeting Factor XI, for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active-Controlled Phase 2 Study
1个月前
已完结
The Natural Course of Serum D-Dimer, C-Reactive Protein, and Erythrocyte Sedimentation Rate Levels After Uneventful Primary Total Joint Arthroplasty
1个月前
已完结
Chinese consensus on the diagnosis and management of herpes zoster （2022）
2个月前
已完结
RECIST 1.1, irRECIST 1.1, and mRECIST: How to Do
2个月前
已完结
[Consensus on clinical diagnosis, treatment, and prevention of chemotherapy-induced neutropenia in China (2026 edition)]
4个月前
已完结
Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China
5个月前
已完结
PSMA-targeted radioligand therapy with [177Lu]Lu-LNC1011 for metastatic castration-resistant prostate cancer: a pilot study
5个月前
已完结
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
7个月前
已完结
The Therapeutic Significance of HER3 in Non-small Cell Lung Cancer (NSCLC): A Review Study
8个月前
已完结
Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target
8个月前
已完结
皖公网安备34019202002308
